뉴스벤징가
Entera Bio Rebounds As Investors Balance Phase 3 Funding Against Dilution Risk
· 발표
기사 요약
Entera Bio financing lifts ENTX as investors weigh a $275 million cash boost, EB613 funding and dilution risk.
기사 원문에서 발췌했어요.뉴스 본문을 불러오고 있어요.
Entera Bio financing lifts ENTX as investors weigh a $275 million cash boost, EB613 funding and dilution risk.
기사 원문에서 발췌했어요.
댓글 —
댓글을 불러오고 있어요…